June 23, 2021
Mochida Pharmaceutical said on June 22 that it has filed for the Japan approval of MND-2119, a once-daily soft capsule version of its high-purity ethyl icosapentate (EPA) agent Epadel (ethyl icosapentate). This is an upgraded formulation of Epadel that is...read more